1032824-43-3Relevant academic research and scientific papers
Development of Large-Scale Routes to Potent GPR119 Receptor Agonists
Matsuoka, Richard T.,Boros, Eric E.,Brown, Andrew D.,Bullock, Kae M.,Canoy, Will L.,Carpenter, Andrew J.,Cobb, Jeremy D.,Condon, Shannon E.,Deschamps, Nicole M.,Elitzin, Vassil I.,Erickson, Greg,Fang, Jing M.,Igo, David H.,Joshi, Biren K.,Kaldor, Istvan W.,Mitchell, Mark B.,Peckham, Gregory E.,Reynolds, Daniel W.,Salmon, Matthew C.,Sharp, Matthew J.,Tabet, Elie A.,Toczko, Jennifer F.,Wu, Lianming Michael,Zhou, Xiao-Ming M.
, p. 1469 - 1475 (2016/08/30)
Practical and scalable syntheses were developed that were used to prepare multikilogram batches of GSK1292263A (1) and GSK2041706A (15), two potent G protein-coupled receptor 119 (GPR119) agonists. Both syntheses employed relatively cheap and readily avai
BICYCLIC COMPOUNDS AND USE AS ANTIDIABETICS
-
Page/Page column 75, (2010/03/02)
The present invention relates to novel compounds that are useful in the treatment of metabolic disorders, particularly type II diabetes mellitus and related disorders, and also to the methods for the making and use of such compounds.
